Profiel
Virginie Carmignac founded Termino C 2436 AB in 2011.
Ms. Carmignac is also the founder of Merozyne Therapeutics AB.
Actieve functies van Virginie Carmignac
| Bedrijven | Functie | Begin |
|---|---|---|
Merozyne Therapeutics AB
 Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Oprichter | - |
Eerdere bekende functies van Virginie Carmignac
| Bedrijven | Functie | Einde |
|---|---|---|
Termino C 2436 AB
 Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Termino C 243 AB is a holding company that develops therapy treatment for children with muscular disorder. It focuses on muscular dystrophy. The company was founded by Virginie Carmignac and Madeleine Durbeej-Hjalt in 2011 and is headquartered in Lund, Sweden. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Termino C 2436 AB
Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Termino C 243 AB is a holding company that develops therapy treatment for children with muscular disorder. It focuses on muscular dystrophy. The company was founded by Virginie Carmignac and Madeleine Durbeej-Hjalt in 2011 and is headquartered in Lund, Sweden. | Health Technology |
Merozyne Therapeutics AB
Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Health Technology |
